Clinical Trials Directory

Trials / Sponsors / CAGE Bio Inc.

CAGE Bio Inc.

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo
Vitiligo
Phase 12025-07-25
CompletedA Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermat
Atopic Dermatitis (AD)
Phase 22025-04-21
CompletedPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of At
Atopic Dermatitis (AD)
Phase 22024-12-18
CompletedTolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermat
Atopic Dermatitis
Phase 1 / Phase 22022-11-09
CompletedAn Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
Fungal Infection, Onychomycosis, Tinea Unguium
—2022-02-08
CompletedCGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea
Rosacea
Phase 22021-05-07
CompletedClinical Evaluation of the Residual Antimicrobial Activity
Bacterial Overgrowth
EARLY_Phase 12020-06-16
CompletedCGB-400 for the Reduction of Facial Redness and Bumps and Blemishes
Rosacea
Phase 12018-10-26
CompletedCGB-400 for the Reduction of Facial Redness
Rosacea
Phase 12018-10-26
Completed50 Human Subject Repeat Insult Patch Test
Erythema, Sensitisation
N/A2017-01-18